Balyasny Asset Management LLC Novavax Inc Call Options Transaction History

Balyasny Asset Management LLC

  • $58 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$10.71 - $17.11 $513,009 - $819,569
47,900 Added 58.06%
130,400 $1.65 Million
Q2 2024

Aug 14, 2024
BUY
$3.89 - $20.97 $320,925 - $1.73 Million
82,500 New
82,500 $1.04 Million
Q2 2022

Aug 15, 2022
SELL
$36.28 - $75.29 $671,180 - $1.39 Million
-18,500 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$69.73 - $142.9 $1.29 Million - $2.64 Million
18,500 New
18,500 $1.36 Million

Others Institutions Holding NVAX

# of Institutions
290
Shares Held
93.4M
Call Options Held
6.95M
Put Options Held
9.4M
View Full List

About NOVAVAX INC

NVAX Quotes by TradingView
  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $666M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email